Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli

被引:583
作者
Buechler, C [1 ]
Ritter, M [1 ]
Orsó, E [1 ]
Langmann, T [1 ]
Klucken, J [1 ]
Schmitz, G [1 ]
机构
[1] Klinikum Univ Regensburg, Inst Klin Chem & Lab Med, D-93042 Regensburg, Germany
关键词
interleukin-10; interferon-gamma; inflammation; tumor necrosis factor alpha;
D O I
10.1002/jlb.67.1.97
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD163, also referred to as M130, member of the scavenger receptor cysteine-rich family (SRCR) is exclusively expressed on cells of the monocyte lineage. In freshly isolated monocytes the CD14(bright) CD16(+) monocyte subset revealed the highest expression of CD163 among all monocyte subsets. CD163 mRNA and protein expression is up-regulated during macrophage colony-stimulating factor (M-CSF)-dependent phagocytic differentiation of human blood monocytes, In contrast, monocytic cells treated with GM-CSF and interleukin-4 (IL-P) for dendritic differentiation down-regulate this antigen. CD163 expression is also suppressed by proinflammatory mediators like lipopolysaccharide (LPS), interferon-gamma (IFN-gamma), and tumor necrosis factor alpha, whereas IL-6 and the antiinflammatory cytokine interleukin-10 (IL-10) strongly up-regulate CD163 mRNA in monocytes and macrophage. The effects of the immunosuppressants dexamethasone, cyclosporin A (CA), and cortisol differ in their capacity to influence CD163 mRNA levels, Our results demonstrate that CD163 expression in monocytes/macrophages is regulated by proinflammatory and antiinflammatory mediators, This expression pattern implies a functional role of CD163 in the antiinflammatory response of monocytes.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 48 条
  • [1] Akira S, 1996, Curr Opin Hematol, V3, P87
  • [2] CD6-ligand interactions: a paradigm for SRCR domain function?
    Aruffo, A
    Bowen, MA
    Patel, DD
    Haynes, BF
    Starling, GC
    Gebe, JA
    Bajorath, J
    [J]. IMMUNOLOGY TODAY, 1997, 18 (10): : 498 - 504
  • [3] Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
  • [4] BER-MAC3 - NEW MONOCLONAL-ANTIBODY THAT DEFINES HUMAN MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN
    BACKE, E
    SCHWARTING, R
    GERDES, J
    ERNST, M
    STEIN, H
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (11) : 936 - 945
  • [5] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [6] CONTINUOUS GROWTH AND DIFFERENTIATION OF HUMAN MYELOID LEUKEMIC-CELLS IN SUSPENSION CULTURE
    COLLINS, SJ
    GALLO, RC
    GALLAGHER, RE
    [J]. NATURE, 1977, 270 (5635) : 347 - 349
  • [7] EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO
  • [8] 2-4
  • [9] Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence
    Greaves, DR
    Gough, PJ
    Gordon, S
    [J]. CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (05) : 425 - 432
  • [10] LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN ACCELERATES THE BINDING OF LPS TO CD14
    HAILMAN, E
    LICHENSTEIN, HS
    WURFEL, MM
    MILLER, DS
    JOHNSON, DA
    KELLEY, M
    BUSSE, LA
    ZUKOWSKI, MM
    WRIGHT, SD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) : 269 - 277